Comparing two surgical techniques for anal function after low rectal cancer surgery
Official title: Comparison of Postoperative Anal Function Between Different Anastomosis Techniques(Parks Versus Bacon) in Low Rectal Cancer: A Prospective, Multicentric and Randomized Controlled Study
Run by Sixth Affiliated Hospital, Sun Yat-sen University · NCT05943444 · Data updated 2026-11-12
This study is testing which of two surgical methods helps people with ultra-low rectal cancer have better bowel control and quality of life after surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 256 (estimated) |
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | August 8, 2023 |
| Main results expected | August 8, 2027 |
| Study ends | August 8, 2027 |
| Registry record updated | December 18, 2025 |
| Trial ID | NCT05943444 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men and women aged 18 to 75 with a pathological diagnosis of rectal cancer and specific tumor characteristics suitable for anal preservation surgery.
✕Probably not a fit
Patients with previous colorectal malignancies or those requiring emergency operations due to complications will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the postoperative anal function of patients with ultra-low rectal cancer who undergo either the Parks operation or the Bacon operation. Participants will be assessed for anal function and quality of life one year after surgery, with primary outcomes focusing on the Low Anterior Resection Syndrome (LARS) score. Secondary outcomes will include LARS scores at 3 and 6 months post-surgery, overall quality of life scores, and the incidence of postoperative complications. The goal is to provide clinical evidence that may improve surgical approaches and patient outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved anal function and quality of life for patients undergoing surgery for low rectal cancer.
How similar studies have gone: While similar studies have explored surgical techniques for rectal cancer, this specific comparison of the Parks and Bacon techniques is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Men or women, aged between 18 and 75 years; 2. Pathological diagnosis of rectal cancer before operation, with the distance from the lower edge of the tumor to the dentate line ≤ 3cm by MR imaging; 3. No local complications (including complete/ incomplete obstruction, active bleeding, local invasion of sphincter or levator ani, etc.) before operation; 4. Suitable for anal preservation surgery discussed by MDT; 5. Adequate bone marrow, liver, renal and cardiac function meeting the requirements of surgery and anesthesia; 6. R0 resection is expected technically; 7. Provision of written informed consent. Exclusion Criteria: 1. Previous history of malignant colorectal tumors; 2. Complications such as obstruction and gastrointestinal bleeding that need an emergency operation; 3. Unachievable R0 resection due to invasion of adjacent organs by primary tumor; 4. Multiple primary tumors; 5. History of other malignancy; 6. Participation in other clinical trials within the previous 4 weeks of enrollment; 7. ASA physical status score ≥ IV level and/or ECOG performance status ≥ 2; 8. Intolerance of surgery due to liver, renal, cardiopulmonary or coagulation dysfunction, or underlying diseases; 9. History of serious mental disorders; 10. Women in pregnancy or lactation period; 11. Uncontrolled infection before operation; 12. Unsuitable to be included due to other clinical and laboratory conditions by the judgement of investigators.
Where it's running
-
The Sixth Affiliated Hospital, Sun Yatsen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Jun Huang, MD — Sixth Affiliated Hospital, Sun Yat-sen University
- Study coordinator: Jun Huang, MD
- Email: huangj97@mail.sysu.edu.cn
- Phone: 13926451242
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Characterization of the tumor microenvironment in locally advanced rectal cancer before and during neoadjuvant therapy
This observational study tests how the tumor and immune cells change in locally advanced rectal cancer from baseline to during neoadjuvant therapy using advanced genomic and immune profiling.
-
Neoadjuvant therapy for locally advanced low rectal cancer: adding fruquintinib to short-course radiotherapy with tislelizumab and CAPOX
This study tests whether adding fruquintinib to short-course radiotherapy plus tislelizumab and CAPOX before surgery helps people with locally advanced low rectal cancer achieve a better tumor response.
-
Tailored treatment approaches for low anterior resection syndrome
This study will see if advanced physiological and imaging tests can identify different subtypes of LARS in people after rectal cancer surgery to help match them to better treatments.
-
Antegrade intestinal fluid reinfusion to prevent low anterior resection syndrome in rectal cancer patients with ileostomy
This trial will test whether putting a patient's intestinal fluid back through their ileostomy before it is closed can prevent low anterior resection syndrome in people treated for mid to low rectal cancer.
-
Using fingertip CRP point-of-care tests to spot leaks after elective colorectal surgery
This project will see if daily fingertip CRP point-of-care tests can detect anastomotic leaks early in people having elective colorectal surgery.
-
Gastric preconditioning before esophagectomy for patients at high risk of anastomotic leak
This registry will see if gastric preconditioning by percutaneous angioembolization before esophagectomy changes how often anastomotic leaks happen in people with esophageal cancer who are at high risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.